BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2049 related articles for article (PubMed ID: 9987495)

  • 21. [Neoadjuvant chemotherapy and chemoradiotherapy in the treatment of esophageal cancer].
    Ando N; Ozawa S; Miki H; Suwa T; Kitajima M
    Gan To Kagaku Ryoho; 1995 Nov; 22(13):1878-85. PubMed ID: 7487116
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neoadjuvant chemotherapy versus surgery first for resectable pancreatic cancer (Norwegian Pancreatic Cancer Trial - 1 (NorPACT-1)) - study protocol for a national multicentre randomized controlled trial.
    Labori KJ; Lassen K; Hoem D; Grønbech JE; Søreide JA; Mortensen K; Smaaland R; Sorbye H; Verbeke C; Dueland S
    BMC Surg; 2017 Aug; 17(1):94. PubMed ID: 28841916
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influence of surgical resection and post-operative complications on survival following adjuvant treatment for pancreatic cancer in the ESPAC-1 randomized controlled trial.
    Bassi C; Stocken DD; Olah A; Friess H; Buckels J; Hickey H; Dervenis C; Dunn JA; Deakin M; Carter R; Ghaneh P; Neoptolemos JP; Buchler MW;
    Dig Surg; 2005; 22(5):353-63. PubMed ID: 16293966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjuvant therapy in colorectal cancer.
    Gerard A; Metzger U; Buyse M
    Anticancer Res; 1989; 9(4):1033-5. PubMed ID: 2683989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Future prospects of radiotherapy in pancreatic cancer.
    Fietkau R; Sauer R
    Eur J Surg Oncol; 1991 Apr; 17(2):201-10. PubMed ID: 1707836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Selection of methods for diagnosis and treatment of pancreatic cancer].
    Ozaki H; Kinoshita T; Kosuge T; Shimada K; Yamamoto J; Inoue K
    Gan To Kagaku Ryoho; 1992 Dec; 19(14):2311-8. PubMed ID: 1463336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Chemotherapy and radiochemotherapy of colorectal cancers: adjuvant and palliative therapeutic procedures].
    Porschen R; Bermann A
    Leber Magen Darm; 1994 Jul; 24(4):164-9. PubMed ID: 7523820
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Is there an advantage to neo- or adjuvant chemotherapy in pancreatic cancer?].
    Klapdor R
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1990; ():135-47. PubMed ID: 1724194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Adjuvant chemotherapy in cancers of the gastrointestinal tract (GIT)].
    Obrecht JP
    Wien Med Wochenschr; 1988 Jul; 138(13):323-30. PubMed ID: 3055691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Adjuvant treatment of cancer of the exocrine pancreas].
    Lacaine F; Houry S; Huguier M
    Rev Prat; 1989 Oct; 39(22):1962-4. PubMed ID: 2682992
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant therapy of esophageal cancer.
    Kelsen D
    Can J Surg; 1989 Nov; 32(6):410-4. PubMed ID: 2479457
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer.
    Neoptolemos JP; Stocken DD; Friess H; Bassi C; Dunn JA; Hickey H; Beger H; Fernandez-Cruz L; Dervenis C; Lacaine F; Falconi M; Pederzoli P; Pap A; Spooner D; Kerr DJ; Büchler MW;
    N Engl J Med; 2004 Mar; 350(12):1200-10. PubMed ID: 15028824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evolving strategies for the treatment of adenocarcinoma of the pancreas. A review.
    Ettinghausen SE; Schwartzentruber DJ; Sindelar WF
    J Clin Gastroenterol; 1995 Jul; 21(1):48-60. PubMed ID: 7560834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Esophageal cancer: did combined treatments improve prognosis?].
    Ganem G; Raoul Y; Goudier MJ; Dubray B; Colin P; Extra JM; Hennequin C; Michel-Langlet P; Vignoud J; Bardet E
    Bull Cancer; 1992; 79(8):735-50. PubMed ID: 1467597
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neoadjuvant therapy for colorectal cancer].
    Kotake K; Koyama Y
    Gan To Kagaku Ryoho; 1995 Nov; 22(13):1886-92. PubMed ID: 7487117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Extended neoadjuvant chemotherapy for borderline resectable pancreatic cancer demonstrates promising postoperative outcomes and survival.
    Rose JB; Rocha FG; Alseidi A; Biehl T; Moonka R; Ryan JA; Lin B; Picozzi V; Helton S
    Ann Surg Oncol; 2014 May; 21(5):1530-7. PubMed ID: 24473642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An organized multi-institutional interdisciplinary evaluation of role of radiation therapy alone or combined with chemotherapy in treatment of adenocarcinoma of the gastrointestinal tract.
    Douglass HO; Stablein DM; Thomas PR
    NCI Monogr; 1988; (6):253-7. PubMed ID: 3281030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Is adjuvant intra-operative radiotherapy (IORT) for resectable and unresectable pancreatic carcinoma worthwhile?
    Heijmans HJ; Hoekstra HJ; Mehta DM
    Hepatogastroenterology; 1989 Dec; 36(6):474-7. PubMed ID: 2515137
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenocarcinoma of the pancreas: current management of resectable and locally advanced disease.
    Evans DB; Rich TA; Byrd DR; Ames FC
    South Med J; 1991 May; 84(5):566-70. PubMed ID: 2035074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant radiotherapy and chemotherapy in resectable gastric cancer. A randomized trial of the gastro-intestinal tract cancer cooperative group of the EORTC.
    Bleiberg H; Goffin JC; Dalesio O; Buyse M; Pector JC; Gignoux M; Roussel A; Samana G; Michel J; Gerard A
    Eur J Surg Oncol; 1989 Dec; 15(6):535-43. PubMed ID: 2689236
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 103.